Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07387484Not yet recruiting
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Primary endpoint: Dermatomal sensory spread at 15 minutes. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07387484.